Canada markets closed

Glenmark Pharmaceuticals Limited (GLENMARK.BO)

BSE - BSE Real Time Price. Currency in INR
Add to watchlist
1,265.70+35.05 (+2.85%)
At close: 03:33PM IST
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2024-03-31
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
16,582,700
14,430,260
14,105,260
11,380,950
-
Other Short Term Investments
1,747,830
203,780
328,750
763,990
-
Total Cash
18,330,530
14,634,040
14,434,010
12,144,940
-
Net Receivables
18,584,120
40,986,060
31,011,350
25,720,550
-
Inventory
25,130,510
29,777,910
24,998,330
22,768,330
-
Other Current Assets
12,235,660
11,536,170
2,770,970
3,634,340
-
Total Current Assets
74,280,820
98,737,190
82,823,480
73,595,790
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
35,374,770
74,627,610
66,580,230
57,096,310
-
Accumulated Depreciation
-
-24,157,710
-20,044,730
-15,060,890
-13,806,630
Net property, plant and equipment
35,374,770
50,469,900
46,535,500
42,035,420
-
Goodwill
673,590
736,190
600,190
580,110
-
Intangible Assets
12,672,060
23,606,830
22,253,790
22,769,380
-
Other long-term assets
1,492,310
1,538,570
-15,953,360
17,029,260
-
Total non-current assets
69,305,420
94,979,570
88,009,400
82,439,980
-
Total Assets
143,586,240
193,716,760
170,832,880
156,035,770
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
9,905,960
4,955,820
10,986,050
7,986,120
-
Accounts Payable
25,359,250
23,918,610
22,886,620
22,377,680
-
Other Current Liabilities
2,443,630
78,130
122,190
286,380
-
Total Current Liabilities
58,185,870
50,455,300
46,894,310
42,010,200
-
Non-current liabilities
Long Term Debt
0
38,521,380
25,717,440
38,888,160
-
Deferred taxes liabilities
2,800
429,480
314,950
287,490
-
Deferred revenues
-
1,318,530
1,213,170
1,366,090
1,346,420
Other long-term liabilities
16,910
13,290
9,200
600,750
-
Total non-current liabilities
6,924,900
44,868,870
29,557,370
43,382,840
-
Total Liabilities
65,110,770
95,324,170
76,451,680
85,393,040
-
Stockholders' Equity
Common Stock
282,190
282,170
282,170
282,170
-
Retained Earnings
-
94,570,390
92,109,070
72,336,180
63,296,780
Total stockholders' equity
78,479,270
94,739,230
90,866,470
70,646,270
-
Total liabilities and stockholders' equity
143,586,240
193,716,760
170,832,880
156,035,770
-